دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Joseph R. Bertino, Scientist and Clinical Oncologist.
Chabner, Bruce A. MD 1,,; Canellos, George P. MD 2
doi : 10.1200/JCO.21.02693
Volume 40(14) pgs. 1511-1598 May 10, 2022
Testing for High-Risk Human Papillomavirus in Lower Genital Tract Tumors: If Knowledge Does Not Translate to an Action That Helps Patients-Why Do It?.
Moore, Kathleen N. MD 1,,; Monk, Bradley J. MD 2,
doi : 10.1200/JCO.22.00251
Controlling the Control Arm in Metastatic Castration-Resistant Prostate Cancer Trials: Best Standard of Care or the Minimum Standard of Care?.
Van Wambeke, Simon MD 1,,; Vera-Badillo, Francisco Emilio MD, MSc 2,; Gyawali, Bishal MD, PhD 2,3,4,
doi : 10.1200/JCO.21.02304
Human Papillomavirus Infection Determines Prognosis in Cervical Cancer.
Lei, Jiayao PhD 1,2; Arroyo-Muhr, Laila Sara PhD 1; Lagheden, Camilla BSc 1; Eklund, Carina BSc 1; Nordqvist Kleppe, Sara MSc 1; Elfstrom, Miriam PhD 1; Andrae, Bengt MD 2; Sparen, Par PhD 2; Dillner, Joakim MD, PhD 1; Sundstrom, Karin MD, PhD 1,,
doi : 10.1200/JCO.21.01930
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.
Li, Shuai MD, PhD 1,2,3; Silvestri, Valentina PhD 4; Leslie, Goska MEng 2; Rebbeck, Timothy R. PhD 5,6,; Neuhausen, Susan L. PhD 7; Hopper, John L. PhD 1; Nielsen, Henriette Roed PhD 8; Lee, Andrew CASM 2,; Yang, Xin PhD 2; McGuffog, Lesley 2; Parsons, Michael T. BSc 9; Andrulis, Irene L. PhD 10,11; Arnold, Norbert PhD 12,13,; Belotti, Muriel PhD 14,15; Borg, Ake PhD 16,; Buecher, Bruno MD 14,15; Buys, Saundra S. MD 17; Caputo, Sandrine M. PhD 14,15,; Chung, Wendy K. MD, PhD 18,; Colas, Chrystelle MD, PhD 14,15,; Colonna, Sarah V. MD 17; Cook, Jackie MBBS 19; Daly, Mary B. MD, PhD 20; de la Hoya, Miguel PhD 21,; de Pauw, Antoine PhD 14,15; Delhomelle, Helene PhD 14,15; Eason, Jacqueline MBChB, DM 22; Engel, Christoph MD 23; Evans, D. Gareth MD 24,25,; Faust, Ulrike PhD 26; Fehm, Tanja N. MD 27,; Fostira, Florentia PhD 28; Fountzilas, George MD, PhD 29,30,; Frone, Megan MSc 31,; Garcia-Barberan, Vanesa PhD 21; Garre, Pilar PhD 21; Gauthier-Villars, Marion MD 14,15; Gehrig, Andrea PhD 32; Glendon, Gord MSc 10; Goldgar, David E. PhD 33; Golmard, Lisa PharmD, PhD 14,15; Greene, Mark H. MD 31; Hahnen, Eric PhD 34,35,; Hamann, Ute PhD 36; Hanson, Helen MBBS, MD 37,; Hassan, Tiara MGenCoun 38; Hentschel, Julia PhD 39; Horvath, Judit MD 40; Izatt, Louise PhD 41; Janavicius, Ramunas MD, PhD 42,43; Jiao, Yue PhD 44,45,46; John, Esther M. PhD 47,48; Karlan, Beth Y. MD 49,; Kim, Sung-Won MD, PhD 50; Konstantopoulou, Irene PhD 28,; Kwong, Ava MBBS, FRCS, PhD 51,52,53,; Lauge, Anthony MSc 14,15; Lee, Jong Won PhD 54; Lesueur, Fabienne PhD 44,45,46; Mebirouk, Noura MSc 44,45,46; Meindl, Alfons PhD 55,56; Mouret-Fourme, Emmanuelle MD 14,15; Musgrave, Hannah MSc 57; Ngeow Yuen Yie, Joanne MBBS, MPH 58,59,; Niederacher, Dieter PhD 27; Park, Sue K. MD, PhD 60,61,62; Pedersen, Inge Sokilde PhD 63,64,65; Ramser, Juliane PhD 56; Ramus, Susan J. PhD 66,67; Rantala, Johanna PhD 68; Rashid, Muhammad U. MD, PhD 36,69; Reichl, Florian MD 70; Ritter, Julia PhD 71; Rump, Andreas PhD 72; Santamarina, Marta PhD 73,74,75; Saule, Claire MD 14,15; Schmidt, Gunnar PhD 76; Schmutzler, Rita K. MD 34,35,77,; Senter, Leigha MSc 78,; Shariff, Saba MBBS 79; Singer, Christian F. MD, MPH 70,; Southey, Melissa C. PhD 3,80,81; Stoppa-Lyonnet, Dominique MD, PhD 14,82,83,; Sutter, Christian PhD 84; Tan, Yen PhD 70; Teo, Soo Hwang PhD 38,85,; Terry, Mary Beth PhD 86; Thomassen, Mads PhD 8; Tischkowitz, Marc MD, PhD 87,88; Toland, Amanda E. PhD 89; Torres, Diana PhD 36,90; Vega, Ana PhD 73,74,75; Wagner, Sebastian A. MD 91,; Wang-Gohrke, Shan MD, PhD 92; Wappenschmidt, Barbara PhD 34,35; Weber, Bernhard H. F. PhD 93,94; Yannoukakos, Drakoulis PhD 28; Spurdle, Amanda B. PhD 9; Easton, Douglas F. PhD 2; Chenevix-Trench, Georgia PhD 9; Ottini, Laura MD 4; Antoniou, Antonis C. PhD 2,,
doi : 10.1200/JCO.21.02112
Predicting the Likelihood of Carrying a BRCA1 or BRCA2 Mutation in Asian Patients With Breast Cancer.
Ang, Boon Hong PhD 1; Ho, Weang Kee PhD 1,2; Wijaya, Eldarina MSc 1; Kwan, Pui Yoke BSc 1; Ng, Pei Sze PhD 1; Yoon, Sook Yee MA 1; Hasan, Siti Norhidayu Dip 1; Lim, Joanna M.C. PhD 1; Hassan, Tiara MGenCouns 1; Tai, Mei-Chee PhD 1; Allen, Jamie MSc 3; Lee, Andrew PhD 3,; Taib, Nur Aishah Mohd MS, MBBS 4,5,; Yip, Cheng Har MBBS 6; Hartman, Mikael MD, PhD 7; Lim, Swee Ho MBBS, MMed 8; Tan, Ern Yu MBBS, MMed, DPhil 9,10,11; Tan, Benita K.T. MBBS, MMed, PhD 12,13,14; Tan, Su-Ming MBBS, MMed 15; Tan, Veronique K.M. MBBS, MMed, MSc 12,13,; Ho, Peh Joo PhD 16; Khng, Alexis J. BSc 16; Dunning, Alison M. PhD 17; Li, Jingmei PhD 16; Easton, Douglas F. PhD 3,17,; Antoniou, Antonis C. PhD 3,; Teo, Soo Hwang PhD 1,4,,
doi : 10.1200/JCO.21.01647
Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F.
Damodaran, Senthil MD, PhD 1,,; Zhao, Fengmin PhD 2,; Deming, Dustin A. MD 3,; Mitchell, Edith P. MD 4,; Wright, John J. MD 5; Gray, Robert J. PhD 2,; Wang, Victoria PhD 2; McShane, Lisa M. PhD 6,; Rubinstein, Larry V. PhD 6,; Patton, David R. MS 7; Williams, P. Mickey PhD 8,; Hamilton, Stanley R. MD 9,; Suga, Jennifer M. MD 10; Conley, Barbara A. MD 11; Arteaga, Carlos L. MD 12,; Harris, Lyndsay N. MD 11,; O'Dwyer, Peter J. MD 13,; Chen, Alice P. MD 14,; Flaherty, Keith T. MD 15,
doi : 10.1200/JCO.21.01648
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial.
Morano, Federica MD 1,; Raimondi, Alessandra MD 1; Pagani, Filippo MD 1; Lonardi, Sara MD 2,; Salvatore, Lisa MD 3,4,; Cremolini, Chiara MD 5,6,; Murgioni, Sabina MD 7; Randon, Giovanni MD 1; Palermo, Federica BS 1; Antonuzzo, Lorenzo MD 8,9; Pella, Nicoletta MD 10; Racca, Patrizia MD 11,; Prisciandaro, Michele MD 1; Niger, Monica MD 1,; Corti, Francesca MD 1,; Bergamo, Francesca MD 7; Zaniboni, Alberto MD 12,; Ratti, Margherita MD 13; Palazzo, Michele BS 1; Cagnazzo, Celeste BS 14,; Calegari, Maria Alessandra MD 3; Marmorino, Federica MD 5,6; Capone, Iolanda BS 15; Conca, Elena BS 15; Busico, Adele BS 15; Brich, Silvia BS 15; Tamborini, Elena BS 15; Perrone, Federica BS 15; Di Maio, Massimo MD 16,; Milione, Massimo MD 15; Di Bartolomeo, Maria MD 1,; de Braud, Filippo MD 1,; Pietrantonio, Filippo MD 1,,
doi : 10.1200/JCO.21.02583
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
Advani, Anjali S. MD 1,,; Moseley, Anna MS 2,3,; O'Dwyer, Kristen M. MD 4,; Wood, Brent L. MD, PhD 5,6,; Fang, Min MD, PhD 7,; Wieduwilt, Matthew J. MD, PhD 8,9,; Aldoss, Ibrahim MD 10,; Park, Jae H. MD 11,; Klisovic, Rebecca B. MD 12,; Baer, Maria R. MD 13,; Stock, Wendy MD 14,; Bhave, Rupali R. MD 15; Othus, Megan PhD 2,3,; Harvey, Richard C. PhD 16; Willman, Cheryl L. MD 16,; Litzow, Mark R. MD 17,; Stone, Richard M. MD 18,; Sharon, Elad MD, MPH 19; Erba, Harry P. MD, PhD 20,
doi : 10.1200/JCO.21.01766
Minority Enrollment in Phase II and III Clinical Trials in Urologic Oncology.
Owens-Walton, Jeunice BS 1; Williams, Cheyenne BS 1; Rompre-Brodeur, Alexis MD 1; Pinto, Peter A. MD 1,; Ball, Mark W. MD 1,
doi : 10.1200/JCO.21.01885
Germline Pathogenic Variants in BRCA1 and BRCA2: Malignancies Beyond Female Breast and Ovarian Cancers.
Lieberman, Sari PhD 1,; Goldvaser, Hadar MD 2,3,; Levy-Lahad, Ephrat MD 1,3,,
doi : 10.1200/JCO.22.00003
Ductal Carcinoma In Situ and Breast Cancer Overdiagnosis.
Jatoi, Ismail MD, PhD
doi : 10.1200/JCO.21.02802
Reply to I. Jatoi.
Wright, Jean L. MD; Rahbar, Habib MD; Obeng-Gyasi, Samilia MD; Carlos, Ruth MD; Tjoe, Judy A. MD; Wolff, Antonio MD
doi : 10.1200/JCO.22.00220
Frontline Dual Checkpoint Inhibition in Metastatic Melanoma Over Anti-PD-1 Monotherapy: The Case for a Comparative Randomized Controlled Trial.
Olivier, Timothee MD; Prasad, Vinay MD, MPH
doi : 10.1200/JCO.21.02904
Reply to T. Olivier et al.
Wolchok, Jedd D. MD, PhD; Kluger, Harriet MD; Campigotto, Federico MS; Larkin, James MD, PhD; Hodi, F. Stephen MD
doi : 10.1200/JCO.22.00209
